173 related articles for article (PubMed ID: 16135732)
1. Comorbidities and Charlson score in resected stage I nonsmall cell lung cancer.
Moro-Sibilot D; Aubert A; Diab S; Lantuejoul S; Fourneret P; Brambilla E; Brambilla C; Brichon PY
Eur Respir J; 2005 Sep; 26(3):480-6. PubMed ID: 16135732
[TBL] [Abstract][Full Text] [Related]
2. Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer.
Birim O; Kappetein AP; Bogers AJ
Eur J Cardiothorac Surg; 2005 Nov; 28(5):759-62. PubMed ID: 16157485
[TBL] [Abstract][Full Text] [Related]
3. The effect of comorbidity on stage-specific survival in resected non-small cell lung cancer patients.
Lüchtenborg M; Jakobsen E; Krasnik M; Linklater KM; Mellemgaard A; Møller H
Eur J Cancer; 2012 Dec; 48(18):3386-95. PubMed ID: 22795582
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Charlson comorbidity index and Kaplan-Feinstein index in patients with stage I lung cancer after surgical resection.
Wang CY; Lin YS; Tzao C; Lee HC; Huang MH; Hsu WH; Hsu HS
Eur J Cardiothorac Surg; 2007 Dec; 32(6):877-81. PubMed ID: 17920921
[TBL] [Abstract][Full Text] [Related]
5. Charlson Comorbidity Index predicts patient outcome, in cases of inoperable non-small cell lung cancer treated with radiofrequency ablation.
Simon TG; Beland MD; Machan JT; Dipetrillo T; Dupuy DE
Eur J Radiol; 2012 Dec; 81(12):4167-72. PubMed ID: 22835876
[TBL] [Abstract][Full Text] [Related]
6. Survival after pathological stage IA nonsmall cell lung cancer: tumor size matters.
Birim O; Kappetein AP; Takkenberg JJ; van Klaveren RJ; Bogers AJ
Ann Thorac Surg; 2005 Apr; 79(4):1137-41. PubMed ID: 15797040
[TBL] [Abstract][Full Text] [Related]
7. Proper treatment selection may improve survival in patients with clinical early-stage nonsmall cell lung cancer.
Birim O; Kappetein AP; Goorden T; van Klaveren RJ; Bogers AJ
Ann Thorac Surg; 2005 Sep; 80(3):1021-6. PubMed ID: 16122477
[TBL] [Abstract][Full Text] [Related]
8. Video-assisted thoracoscopic lobectomy for clinical stage I non-small cell lung cancer: experience with 111 consecutive patients demonstrating comorbidity.
Nakanishi R; Nakagawa M; Tokufuchi H; Okumura T; Maeda M; Kuboi S; Kido M
Minerva Chir; 2012 Feb; 67(1):67-75. PubMed ID: 22361678
[TBL] [Abstract][Full Text] [Related]
9. Long-term survival after non-small cell lung cancer surgery: development and validation of a prognostic model with a preoperative and postoperative mode.
Birim O; Kappetein AP; Waleboer M; Puvimanasinghe JP; Eijkemans MJ; Steyerberg EW; Versteegh MI; Bogers AJ
J Thorac Cardiovasc Surg; 2006 Sep; 132(3):491-8. PubMed ID: 16935100
[TBL] [Abstract][Full Text] [Related]
10. Co-morbidity index predicts for mortality after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer.
Kopek N; Paludan M; Petersen J; Hansen AT; Grau C; Høyer M
Radiother Oncol; 2009 Dec; 93(3):402-7. PubMed ID: 19559492
[TBL] [Abstract][Full Text] [Related]
11. Stage IB nonsmall cell lung cancers: are they all the same?
Jones DR; Daniel TM; Denlinger CE; Rundall BK; Smolkin ME; Wick MR
Ann Thorac Surg; 2006 Jun; 81(6):1958-62; discussion 1962. PubMed ID: 16731113
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of prognostic factors in 1826 patients with completely resected non-small cell lung cancer].
Gao YS; Xing XZ; Shao K; Feng XL; He J
Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):134-7. PubMed ID: 18646698
[TBL] [Abstract][Full Text] [Related]
13. Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials.
Asmis TR; Ding K; Seymour L; Shepherd FA; Leighl NB; Winton TL; Whitehead M; Spaans JN; Graham BC; Goss GD;
J Clin Oncol; 2008 Jan; 26(1):54-9. PubMed ID: 18165640
[TBL] [Abstract][Full Text] [Related]
14. Results and impact of routine assessment of comorbidity in elderly patients with non-small-cell lung cancer aged > 80 years.
Breen D; Barlési F; Zemerli M; Doddoli C; Torre JP; Thomas P; Astoul P
Clin Lung Cancer; 2007 Mar; 8(5):331-4. PubMed ID: 17562233
[TBL] [Abstract][Full Text] [Related]
15. Influence of age on choice of therapy and surgical outcomes in patients with nonsmall cell lung cancer.
Bolton WD; Rice DC; Correa AM; Hofstetter W; Komaki R; Mehran R; Pisters K; Roth JA; Vaporciyan AA; Walsh GL; Swisher SG
Am Surg; 2009 Jul; 75(7):598-603; discussion 603-4. PubMed ID: 19655604
[TBL] [Abstract][Full Text] [Related]
16. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.
Lagerwaard FJ; Verstegen NE; Haasbeek CJ; Slotman BJ; Paul MA; Smit EF; Senan S
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):348-53. PubMed ID: 22104360
[TBL] [Abstract][Full Text] [Related]
18. The side of pneumonectomy influences long-term survival in stage I and II non-small cell lung cancer.
Simón C; Moreno N; Peñalver R; González G; Alvarez-Fernández E; González-Aragoneses F;
Ann Thorac Surg; 2007 Sep; 84(3):952-8. PubMed ID: 17720406
[TBL] [Abstract][Full Text] [Related]
19. Inequalities in outcomes for non-small cell lung cancer: the influence of clinical characteristics and features of the local lung cancer service.
Rich AL; Tata LJ; Free CM; Stanley RA; Peake MD; Baldwin DR; Hubbard RB
Thorax; 2011 Dec; 66(12):1078-84. PubMed ID: 21785158
[TBL] [Abstract][Full Text] [Related]
20. Performance at preoperative stair-climbing test is associated with prognosis after pulmonary resection in stage I non-small cell lung cancer.
Brunelli A; Pompili C; Berardi R; Mazzanti P; Onofri A; Salati M; Cascinu S; Sabbatini A
Ann Thorac Surg; 2012 Jun; 93(6):1796-800. PubMed ID: 22551844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
